Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Wellcome Open Res ; 8: 362, 2023.
Article in English | MEDLINE | ID: mdl-38774491

ABSTRACT

We present a genome assembly from an individual Eptesicus nilssonii (the northern bat; Chordata; Mammalia; Chiroptera; Vespertilionidae), derived from the placental tissue of a pregnancy that resulted a male pup. The genome sequence is 2,064.1 megabases in span. Most of the assembly is scaffolded into 26 chromosomal pseudomolecules, including the X and Y sex chromosomes. The mitochondrial genome has also been assembled and is 17.04 kilobases in length.

2.
Eur J Clin Microbiol Infect Dis ; 39(1): 213, 2020 01.
Article in English | MEDLINE | ID: mdl-31782024

ABSTRACT

Two affiliations of author John Christopher Noone were not included in the original article and have been added here. Also, Acknowledgments of the originally published article is not complete. Please see the corrected section below.

3.
Eur J Clin Microbiol Infect Dis ; 38(7): 1367-1376, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31025134

ABSTRACT

Norway has one of the world's highest incidences of colorectal cancer (CRC). Accumulating research suggests that the intestinal microbiota may have an important role in initiation and progression of colorectal cancer. In order to evaluate microbiome-based biomarkers for non-invasive detection of CRC, the levels of Fusobacterium nucleatum and selected Escherichia coli toxin genes in stool and mucosa from a small cohort of Norwegian patients were investigated. The study cohort included 72 patients scheduled for colonoscopy. The patients were divided into three groups upon their examinations: cancer, polyp, and control groups. Levels of F. nucleatum in stool samples were significantly higher in the cancer group compared with the control group and the polyp group. High levels of F. nucleatum in stool reflected detection of F. nucleatum in the tumor tissues of colorectal cancer patients. However, no difference in the levels of E. coli toxin genes in neither stool nor biopsy samples between the patient groups was observed. This study suggests that a quantitative PCR assay targeting F. nucleatum in stool samples has the potential to be included in a larger panel of biomarkers for non-invasive testing for colorectal cancer.


Subject(s)
Colon/microbiology , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/microbiology , Feces/microbiology , Fusobacterium nucleatum/isolation & purification , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy , Cohort Studies , Colon/pathology , Colonoscopy , Early Detection of Cancer/methods , Escherichia coli/genetics , Female , Fusobacterium Infections/complications , Gastrointestinal Microbiome , Humans , Male , Middle Aged , Norway , Real-Time Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...